Analysed PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) News Sources
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
20-04-2026
yahoo.com
Assessing Phathom Pharmaceuticals (PHAT) Valuation After Strong One Year Shareholder Return
17-04-2026
yahoo.com
Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight
13-04-2026
yahoo.com
What is the current price of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The current price of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is $12.88.
PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) since the previous trading day is $-0.59.
PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) since the previous trading day is -4.3801%.
What is the most recent average sentiment score for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The most recent average sentiment score for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)?
The most recent sentiment for PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ) is .
SEC-8K** Filing Available For PHATHOM PHARMACEUTICALS INC (PHAT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.